EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma

Author： Sundvall Maria Karrila Anna Nordberg Janne Grénman Reidar Elenius Klaus

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.15, Iss.2, 2010-06, pp. : 185-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual EGFR and COX-2 Inhibition as a Novel Approach to Targeting Head and Neck Squamous Cell Carcinoma

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 931-937

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR inhibition as a therapy for head and neck squamous cell carcinoma

By Loeffler-Ragg Judith Schwentner Ilona Sprinzl Georg M Zwierzina Heinz

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 10, 2008-10 ,pp. : 1517-1531

Informa Healthcare

Access to resources Recommend Favorite

Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma

By Cassell Andre Grandis Jennifer R

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 6, 2010-06 ,pp. : 709-722

Informa Healthcare

Access to resources Recommend Favorite

Afatinib in the treatment of head and neck squamous cell carcinoma

By Ferrarotto Renata Gold Kathryn A

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 135-143

Informa Healthcare

Access to resources Recommend Favorite

Current and future directions in the treatment of squamous cell carcinoma of the head and neck: multidisciplinary symposium on head and neck cancer

By Haddad Robert

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 333-336

Informa Healthcare

Access to resources Recommend Favorite